The Levels of Serum B12, Folic Acid and Homocysteine in the Thromboembolic Diseases

Basit Öğe Kaydı
dc.contributor.authorKarabulut, Keziban Ucar
dc.contributor.authorBayir, Aysegul
dc.contributor.authorKara, Fatih
dc.contributor.authorAk, Ahmet
dc.date.accessioned2020-03-26T19:43:03Z
dc.date.available2020-03-26T19:43:03Z
dc.date.issued2017
dc.departmentSelçuk Üniversitesien_US
dc.description.abstractThe aim of this study was to examine the levels of serum B12, folic acid, and homocysteine at admission in the cases established at the emergency department with thrombo-embolic diseases and to compare them with healthy subjects and also compare the diagnosis groups with each other. Material and Method: This study included 100 subjects diagnosed at the emergency department between March 2009-May 2009 with acute myocardial infarction, acute pulmonary embolism, deep vein thrombosis, ischemic cerebrovascular disease, acute mesenteric embolism, peripheral artery embolism and 110 healthy voluntary subjects were included in the control group. Vitamin B12, folic acid, and homocysteine levels were examined in blood samples obtained at admission. Mann-Whitney U test was used to compare the patient and control group. Kruskal-Wallis variance analysis was used to compare the patient group, according to diagnosis. p <= 0.05 was considered as significant. Results: Mean serum homocysteine and plasma vitamin B12 levels were significantly higher in the patient group than control group (p= 0.002, 0.000 respectively). Mean serum B12 values of acute myocardial infarction and Ischemic Cerebrovascular Disease groups in the patient group were significantly lower than those of the control group (p< 0.05). Serum folic acid values of peripheral artery embolism and acute myocardial infarction groups were considerably lower than the control group (p< 0.05). Plasma homocysteine levels were significantly higher in all patient groups according to their diagnosis than the control group (p< 0.05). Discussion: Serum vitamin B12 and folic acid levels in the acute period of thromboembolic diseases of ST-elevation myocardial infarction, non-ST elevation myocardial infarction, pulmonary embolism, and ischemic cerebrovascular disease are lower than those of other thromboembolic diseases. Plasma homocysteine levels are high during the acute period of all thromboembolic diseases; they are at the highest levels in acute pulmonary embolism, ST-elevation myocardial infarction, and non-ST elevation myocardial infarction which have high morbidity and mortality rates when compared with the other thromboembolic diseases.en_US
dc.identifier.doi10.4328/JCAM.4777en_US
dc.identifier.endpage133en_US
dc.identifier.issn1309-0720en_US
dc.identifier.issn1309-2014en_US
dc.identifier.issue2en_US
dc.identifier.pmid#YOKen_US
dc.identifier.scopusqualityN/Aen_US
dc.identifier.startpage130en_US
dc.identifier.urihttps://dx.doi.org/10.4328/JCAM.4777
dc.identifier.urihttps://hdl.handle.net/20.500.12395/35590
dc.identifier.volume8en_US
dc.identifier.wosWOS:000396415800011en_US
dc.identifier.wosqualityN/Aen_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakScopusen_US
dc.language.isoenen_US
dc.publisherDERMAN MEDICAL PUBLen_US
dc.relation.ispartofJOURNAL OF CLINICAL AND ANALYTICAL MEDICINEen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.selcuk20240510_oaigen_US
dc.subjectVitamin B12en_US
dc.subjectFolic Aciden_US
dc.subjectHomocysteineen_US
dc.titleThe Levels of Serum B12, Folic Acid and Homocysteine in the Thromboembolic Diseasesen_US
dc.typeArticleen_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu